Search…

Lates News

03/04/2026

According to AI Express, Huaxin Securities issued a research report on April 3, giving Lianyin Biosciences (002166.SZ) a "buy" rating. The main reasons for the rating include: 1) The decline in gross margin, cost increases, and depreciation amortization; 2) Steady growth in natural sweeteners, good performance of tea extracts; 3) Smooth progress in synthetic biology business, smooth progress in formula applications. (Daily Economic News)

Latest

4 m ago

The General Office of the National Bureau of Statistics issued a public announcement seeking opinions on the "Guide to Data Property Registration Work".

5 m ago

Japanese media: An unknown individual set fire to the Shibuya intersection in Tokyo and fled, police are currently in pursuit.

7 m ago

Janney Montgomery Scott's chief investment strategist Mark Luschini said: The non-farm payroll report is mixed, but overall strong enough to support the Federal Reserve's decision to stand pat. The downward revision of the data weakened the overall figures, and the slowing wage growth may indicate some slack in the labor market. But the most important point is that the unemployment rate did not see a significant increase, which is a positive sign for the economy.

9 m ago

Hainan Haiyao: Intends to reduce its stake in China Antibody by no more than 5%.

9 m ago

Shi Xiaolin meets with Zhang Yi, President of China Construction Bank.

See all latest